References
Swanson R, Cook R (1977) Drugs, chemicals and blood dyscrasias. Drug Intelligence Publications, Hamilton, Illinois
Bithell TC, Wintrobe MM (1967) Drug-induced aplastic anemia. Semin Hermatol 4: 194–221
Wallerstein RO, Condit PK, Kasper CK, Brown JW, Morrison FR (1969) Statewide study of chloramphenicol therapy and fatal aplastic anemia. J Am Med Assoc 208: 2045–2050
Palva IP, Mastala OO (1970) Drug-induced agranulocytosis with special reference to aminophenazone. 1. Adults. Acta Med Scand 187: 109–115
Westerholm B, Reizenstein P (1971) Drug-induced agranulocytosis. In: Baker, SB de C (ed) Correlation of adverse effects in man with observations in animals. Excerpta Med, International Congress Series 220: 217–221
Böttiger LE, Westerholm B (1972) Aplastic anemia. I. Incidence and aetiology. Acta Med Scand 192: 315–318
Böttiger LE, Westerholm B (1972) Aplastic anemia. III. Aplastic anemia and infectious hepatitis. Acta Med Scand 192: 323–326
Kantero I, Mustala OO, Palva IP (1972) Drug-induced agranulocytosis with special reference to aminophenazone. IV. Children. Acta Med Scand 192: 327–330
Böttiger LE, Westerholm B (1973) Drug-induced blood dyscrasias in Sweden. Brit Med J 3: 339–343
Modan B, Segal S, Shani M, Sheba C (1975) Aplastic anemia in Israel: Evaluation of the etiological role of chloramphenicol on a community-wide basis. Am J Med Sci 270: 441–445
Arneborn P, Palmblad J (1978) Drug-induced neutropenia in the Stockholm region 1973–75: Frequency and causes. Acta Med Scand 204: 283–286
Böttiger LE, Westerholm B (1979) Drug-induced blood dyscrasias. Acta Med Scand 205: 457–461
Arneborn P, Palmblad J (1979) Drug-induced neutropenia in the Stockholm region 1976–77. Acta Med Scand 206: 241–243
Varonos DD, Santamouris S, Karambali S (1979) The incidence of dipyrone-induced agranulocytosis in Greece during 1975. J Int Med Res 7: 564–568
Aoki K, Fujiki M, Shumiza H, Ohno Y (1980) Geographic and ethnic differences of aplastic anemia in humans. In: Najean Y (ed) Medullary Aplasia. Masson, New York, p 79–89
Böttiger LE, Böttiger B (1981) Incidence and cause of aplastic anemia, hemolytic anemia, agranulocytosis and thrombocytopenia. Acta Med Scand 210: 475–479
Author information
Authors and Affiliations
Additional information
Participants are as follows Chairman: M.Levy, Jerusalem;Coordination and Data Analysis (Drug Epidemiology Unit): D.Slone, S.Shapiro, T.Anderson, L.J.Blair, P.T.Cook, J.J.Farrell, L.F.Gaetano, D.W.Kaufman, Boston;Investigators: J.R.Laporte, Barcelona; H.Kewitz, Berlin; G.Retsagi, S.Hollan, Budapest; M.Levy, Z.Stern, Jerusalem; G. Tognoni, Milan; H.Heimpel, W.Heit, Ulm;Data Collection: X.Carne, L.Ibanez, Barcelona; M.Klein, C.Scott, Berlin; E.Czink, A.Laszlo, Budapest; M.Beiski, F.Simon, Z.Toledano, Jerusalem; C.LaVecchia, P.Liati, M.G.Zurlo, Milan; I.Bayer, R.Kreuzer, Ulm;Epidemiological Consulatation: O.S.Miettinen, Boston;Hematology Review Committee: H.Heimpel, W.Heit, Ulm; G.Lambertenghi, Milan; A.Polliack, Jerusalem
Dr. Slone died on May 10, 1982
Rights and permissions
About this article
Cite this article
Shapiro, S. The design of a study of the drug etiology of agranulocytosis and aplastic anemia. Eur J Clin Pharmacol 24, 833–836 (1983). https://doi.org/10.1007/BF00607096
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00607096